Patent ID: 11897944
Assignee: ABLYNX N.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The ISVD according to claim 1, further comprising:
a leucine (L), a lysine (K), or a valine (V) at Kabat position 11;
an alanine (A) or a proline (P) at Kabat position 14;
an alanine (A), a leucine (L), a proline (P), a serine (S), or a threonine (T) at Kabat position 41;
a glutamic acid (E) or a glycine (G) at Kabat position 42;
an alanine (A) or a threonine at Kabat position 87;
an alanine (A), a leucine (L), or a threonine at Kabat position 89;
a leucine (L) at Kabat position 108;
a lysine (K) or a glutamine (Q) at Kabat position 110;
a lysine (K) or a glutamine (Q) at Kabat position 112; or
a combination thereof.